177 related articles for article (PubMed ID: 33564442)
1. Effects of a medium cut-off (Theranova
Cozzolino M; Magagnoli L; Ciceri P; Conte F; Galassi A
Clin Kidney J; 2021 Jan; 14(1):382-389. PubMed ID: 33564442
[TBL] [Abstract][Full Text] [Related]
2. Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study.
Ciceri P; Tettamanti G; Galassi A; Magagnoli L; Fabresse N; Alvarez JC; Massy ZA; Messa P; Cozzolino M
Clin Kidney J; 2021 Jul; 14(7):1798-1807. PubMed ID: 34221387
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial.
Belmouaz M; Bauwens M; Hauet T; Bossard V; Jamet P; Joly F; Chikhi E; Joffrion S; Gand E; Bridoux F
Nephrol Dial Transplant; 2020 Feb; 35(2):328-335. PubMed ID: 31578564
[TBL] [Abstract][Full Text] [Related]
4. Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.
Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho YJ; Wong MG; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Darssan D; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
BMC Nephrol; 2018 Apr; 19(1):89. PubMed ID: 29665795
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration.
García-Prieto A; Vega A; Linares T; Abad S; Macías N; Aragoncillo I; Torres E; Hernández A; Barbieri D; Luño J
Clin Kidney J; 2018 Oct; 11(5):742-746. PubMed ID: 30288272
[TBL] [Abstract][Full Text] [Related]
6. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
[TBL] [Abstract][Full Text] [Related]
7. Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.
Kim TH; Kim SH; Kim TY; Park HY; Jung KS; Lee MH; Jhee JH; Lee JE; Choi HY; Park HC
BMC Nephrol; 2019 Dec; 21(1):2. PubMed ID: 31892319
[TBL] [Abstract][Full Text] [Related]
8. Middle molecule elimination in expanded haemodialysis: only convective transport?
Macías N; Vega A; Abad S; Aragoncillo I; García-Prieto AM; Santos A; Torres E; Luño J
Clin Kidney J; 2019 Jun; 12(3):447-455. PubMed ID: 31198548
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2 medium cutoff dialyzers versus on-line hemodiafiltration regarding depurative ability and albumin loss: An uncontrolled clinical research.
Martínez-Miguel P; Gimena Muñoz R; Barrionuevo González M; López-Ongil S; Moro MÁ; Lizasoain I; Rodríguez-Puyol D; García Segura JM
Artif Organs; 2023 Mar; 47(3):589-594. PubMed ID: 36420938
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial.
Weiner DE; Falzon L; Skoufos L; Bernardo A; Beck W; Xiao M; Tran H
Clin J Am Soc Nephrol; 2020 Sep; 15(9):1310-1319. PubMed ID: 32843372
[TBL] [Abstract][Full Text] [Related]
11. Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration.
de Sequera P; Pérez-García R; Vega A; Martínez-Vaquera S; Acosta JG; Pérez Del Valle K; Fernández-Lucas M; García-Rubiales MA; García-Herrera AL; Coll E; Mérida E; Martínez-Miguel P; Castaño I; Gil-Casares B; Garro J; Maduell F;
Clin Kidney J; 2023 Nov; 16(11):2254-2261. PubMed ID: 37915938
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four medium cut-off dialyzers.
Maduell F; Broseta JJ; Rodríguez-Espinosa D; Del Risco J; Rodas LM; Arias-Guillén M; Vera M; Fontseré N; Salgado MDC; Rico N
Clin Kidney J; 2022 Dec; 15(12):2292-2299. PubMed ID: 36381368
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of expanded hemodialysis with the Theranova 400 dialyzer: A post hoc evaluation of a randomized clinical trial in the United States.
Blackowicz MJ; Falzon L; Beck W; Tran H; Weiner DE
Hemodial Int; 2022 Jul; 26(3):449-455. PubMed ID: 35441486
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer.
Maduell F; Broseta JJ; Rodríguez-Espinosa D; Del Risco-Zevallos J; Gómez M; Rodas LM; Arias-Guillén M; Vera M; Fontseré N; Salgado MDC; Rico N
Blood Purif; 2023; 52(1):68-74. PubMed ID: 35551384
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
[TBL] [Abstract][Full Text] [Related]
16. Effects of Medium Cut-Off Versus High-Flux Hemodialysis Membranes on Biomarkers: A Systematic Review and Meta-Analysis.
Kandi M; Brignardello-Petersen R; Couban R; Wu C; Nesrallah G
Can J Kidney Health Dis; 2022; 9():20543581211067090. PubMed ID: 35070336
[TBL] [Abstract][Full Text] [Related]
17. Performance of hemodialysis with novel medium cut-off dialyzers.
Kirsch AH; Lyko R; Nilsson LG; Beck W; Amdahl M; Lechner P; Schneider A; Wanner C; Rosenkranz AR; Krieter DH
Nephrol Dial Transplant; 2017 Jan; 32(1):165-172. PubMed ID: 27587605
[TBL] [Abstract][Full Text] [Related]
18. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R
Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506
[TBL] [Abstract][Full Text] [Related]
19. Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic Toxins.
Belmouaz M; Goussard G; Joly F; Sibille A; Martin C; Betous T; Thierry A; Bauwens M; Bridoux F
Blood Purif; 2023; 52(3):309-318. PubMed ID: 36215951
[TBL] [Abstract][Full Text] [Related]
20. Medium Cut-Off versus Low-Flux Dialyzers in Hemodialysis Patients with COVID-19: Clinical Outcomes and Reduction in Interleukin-6.
Pongsittisak W; Satpanich P; Jaturapisanukul S; Keawvichit R; Prommool S; Trakranvanich T; Ngamvichukorn T; Kurathong S
Blood Purif; 2023; 52(6):591-599. PubMed ID: 37231799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
